BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 9498749)

  • 1. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
    Purkerson JM; Parker DC
    J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
    Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
    Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells.
    Li YY; Baccam M; Waters SB; Pessin JE; Bishop GA; Koretzky GA
    J Immunol; 1996 Aug; 157(4):1440-7. PubMed ID: 8759724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line.
    Kumar G; Wang S; Gupta S; Nel A
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):215-23. PubMed ID: 7717978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
    Lee JR; Koretzky GA
    J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL; Krebs DL; Gold MR
    J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
    Calleja V; Ruiz Enríquez P; Filloux C; Peraldi P; Baron V; Van Obberghen E
    Endocrinology; 1997 Mar; 138(3):1111-20. PubMed ID: 9048617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line.
    Kumar G; Gupta S; Wang S; Nel AE
    J Immunol; 1994 Nov; 153(10):4436-47. PubMed ID: 7963520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade.
    Li X; Carter RH
    J Immunol; 1998 Dec; 161(11):5901-8. PubMed ID: 9834070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
    Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
    J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases.
    Berberich I; Shu G; Siebelt F; Woodgett JR; Kyriakis JM; Clark EA
    EMBO J; 1996 Jan; 15(1):92-101. PubMed ID: 8598210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
    Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
    J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases.
    Luttrell LM; Daaka Y; Della Rocca GJ; Lefkowitz RJ
    J Biol Chem; 1997 Dec; 272(50):31648-56. PubMed ID: 9395506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells.
    Sakata N; Patel HR; Terada N; Aruffo A; Johnson GL; Gelfand EW
    J Biol Chem; 1995 Dec; 270(51):30823-8. PubMed ID: 8530526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
    Swart JM; Bergeron DM; Chiles TC
    J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation.
    Gold MR; Sanghera JS; Stewart J; Pelech SL
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):269-76. PubMed ID: 1384467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human type II Fcgamma receptors inhibit B cell activation by interacting with the p21(ras)-dependent pathway.
    Sármay G; Koncz G; Gergely J
    J Biol Chem; 1996 Nov; 271(48):30499-504. PubMed ID: 8940017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells.
    Sakata N; Kawasome H; Terada N; Gerwins P; Johnson GL; Gelfand EW
    Eur J Immunol; 1999 Sep; 29(9):2999-3008. PubMed ID: 10508274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.